NL-OMON43836已完成4 期
Markers of Efficacy of Xolair (Omalizumab) in Chronic Spontaneous Urticaria - U-MEX
niversitair Medisch Centrum Utrecht0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Age * 18 years
- •Diagnosis of CSU according to recent international guidelines
- •Moderate or severe disease activity (UAS7 * 16) despite current treatment with H1 antihistamines according to recent international guidelines
- •Sufficient washout of treatment with immunosuppressants (several washout periods are pre-defined).
排除标准
- •Other urticarias than CSU, including but not limited to CINDU
- •Hypersensitivity to omalizumab or any component of the formulation
研究者
相似试验
已完成
不适用
Management of gum recession using two types of membranes derived from bloodCTRI/2022/04/042040Kavitha Sridhar4
招募中
不适用
Evaluation of the effect of the drug Ketorolac Trometamol compared with physiotherapy treatment in patients with temporomandibular dysfunctioTemporomandibular joint disordersFacial painC23.888.592.612.330K07.6RBR-5wsz24niversidade Federal do Ceará
已完成
4 期
Clinical Performance of the Endeavor Zotarolimus-Eluting Stent in Real-world Japanese Patients: A Prospective Multicenter RegistryIschemic Heart Disease/Coronary Artery DiseaseJPRN-UMIN000008076Associations for Establishment of Evidence in Interventions1,000
招募中
Unknown
Evaluation of two chemical agents in gingival graft surgeriesPostoperative careC07.465.714.258Gingival recessionRBR-93ccq38niversidade de São Paulo
已完成
不适用
Clinical evaluation of efficacy and safety of CLARITH Tablets 200 mg (800mg/day) against community acquired bacterial pneumonia.community acquired bacterial pneumoniaJPRN-UMIN000004745Organization of Clinical Trials for Respiratory and Infectious Disease20